NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









WntRx Pharmaceuticals

WntRx Pharmaceuticals

Private
Boston, MassachusettsHealthcare & Life Scienceshttp://wntrxpharm.com/

Last Round

Accelerator

Feb 29, 2016

Total Funding Raised

$1.5M

Company Overview

WntRx Pharmaceuticals is a biotechnology company that develops non-toxic, oncogenic-specific Wnt pathway inhibitors for the treatment of various cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncology therapeuticsWnt signaling pathwaystapled-peptide inhibitorsantibody-drug conjugatesADCcancer drug discoverybiotech startuptargeted cancer therapybiologicsdrug licensingpre-clinical biotechprecision medicinedrug pipelinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WntRx Pharmaceuticals Comparables

Compare WntRx Pharmaceuticals with similar companies based on industry and business-model similarity.

WntRx Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sapience Therapeutics
86%
StemSynergy Therapeutics, Inc.
81%
Iterion Therapeutics
79%

WntRx Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 29, 2016
AcceleratorSep 1, 2015
SeedJul 1, 2015
AcceleratorJul 1, 2014
AngelMay 1, 2014

WntRx Pharmaceuticals Investors

Notable investors and investment history

WntRx Pharmaceuticals investors
InvestorRounds
Harvard Innovation LabsAccelerator
TSV CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 29, 2016

    Raised an Accelerator round with MassBio and MassCONNECT.

  • Jul 1, 2014

    Received funding from LabCentral.

WntRx Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

WntRx Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about WntRx Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2013
Last FundingFeb 29, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.